Subscribe
Subscribe for the Newsletter
Mobile Navigation
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Experience
Market Research
Directory
Close
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Dan Peizer Reveals Catalant’s Newest Acquisition
N
Nice Insight
Apr 12, 2017
PTV-M11-16-AP-027
Drug Delivery
Drug Discovery and Development
Biologics - Large Molecule
PA TV (video)
Dan Peizer, Global Director of Corporate Marketing, Catalent
Related Content
AI-Designed ADC
Closing the Loop Between AI Design and Clinical Translation
David Alvaro, Ph.D.; Peyton Greenside
Pharma's Almanac
PAO-11-26-CL-02
Nov 20, 2026
Diabetes Cell Tx
The Next Generation of Diabetes Cell Replacement Therapies
David Alvaro, Ph.D.
Pharma's Almanac
PAO-11-26-PA-09
Nov 18, 2026
Perfusion
From Fed-Batch to Continuous Processes: How Perfusion Enables Smarter Biologics Production
Seohyeon Song
Samsung Biologics
PAO-10-26-CL-07
Nov 16, 2026
PAMCPs
Post-Approval Change Management and the Promise of ICH Q12
Pharma's Almanac
PAO-11-26-PA-07
Nov 11, 2026
Biologics CDMO
What Drug Developers Should Look for in a Long-Term Biologics Manufacturing Partner
Angelika Rublack
IDT Biologika
PAO-10-26-CL-11
Nov 10, 2026
MASH
MASH Drug Development Enters a New Era
Pharma's Almanac
PAO-11-26-PA-06
Nov 9, 2026
Parasitic Diseases
Therapeutics and Vaccines for Parasitic Infections: A Quick Overview and Recent Advances
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-11-26-PA-05
Nov 6, 2026
Fed-Batch
Advancing S-Tensify™ Through Cell-Line-Specific Process Optimization
Minyong Eom; Hakyung Kim; Dongyoung Park; Sojeong Lee, Ph.D.; Daegyun Lee
Samsung Biologics
PAO-10-26-CL-12
Nov 5, 2026
Analytical Strategy
Analytical Strategy as a Competitive Advantage in Biologics Development
Dr. Dietmar Mayer
IDT Biologika
PAO-10-26-CL-10
Nov 5, 2026
Metabolic Disease
Precision Medicine in Metabolic Disease: Can We Predict Who Responds to Which Therapy?
David Alvaro, Ph.D.
Pharma's Almanac
PAO-11-26-PA-04
Nov 5, 2026
Sustainability
How is sustainability shifting from a reporting exercise to a design constraint in manufacturing and development?
Pharma's Almanac
PAO-10-26-RT-01
Oct 30, 2026
Antibody Data
Does Antibody Development Have a Data Problem?
Sophie Lutter, Ph.D.
Lab Thread
PAO-10-26-CL-08
Oct 26, 2026
Previous slide
Next slide